BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6094045)

  • 1. Apparent mineralocorticoid excess and deficient 11 beta-oxidation of cortisol in a young female.
    Harinck HI; van Brummelen P; Van Seters AP; Moolenaar AJ
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):505-14. PubMed ID: 6094045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Rodríguez JA
    Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New findings in apparent mineralocorticoid excess.
    DiMartino-Nardi J; Stoner E; Martin K; Balfe JW; Jose PA; New MI
    Clin Endocrinol (Oxf); 1987 Jul; 27(1):49-62. PubMed ID: 2820623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
    Al-Harbi T; Al-Shaikh A
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1083-8. PubMed ID: 23329753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
    Stewart PM; Corrie JE; Shackleton CH; Edwards CR
    J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The syndrome of apparent mineralocorticoid excess.
    Cooper M; Stewart PM
    QJM; 1998 Jul; 91(7):453-5. PubMed ID: 9797927
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertension in a four-year-old child: gas chromatographic and mass spectrometric evidence for deficient hepatic metabolism of steroids.
    Shackleton CH; Honour JW; Dillon MJ; Chantler C; Jones RW
    J Clin Endocrinol Metab; 1980 Apr; 50(4):786-02. PubMed ID: 6988456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-renin, low-aldosterone hypertension and abnormal cortisol metabolism in a 19-month-old child.
    Fiselier TJ; Otten BJ; Monnens LA; Honour JW; van Munster PJ
    Horm Res; 1982; 16(2):107-14. PubMed ID: 7049881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent mineralocorticoid excess causing hypertension and hypokalemia in children.
    New MI; Stoner E; DiMartino-Nardi J
    Clin Exp Hypertens A; 1986; 8(4-5):751-72. PubMed ID: 3463439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension.
    New MI; Levine LS; Biglieri EG; Pareira J; Ulick S
    J Clin Endocrinol Metab; 1977 May; 44(5):924-33. PubMed ID: 870517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess.
    Ulick S; Tedde R; Mantero F
    J Clin Endocrinol Metab; 1990 Jan; 70(1):200-6. PubMed ID: 2403571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid hypertension in childhood.
    New MI; Levine LS
    Mayo Clin Proc; 1977 May; 52(5):323-8. PubMed ID: 323586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess.
    Oberfield SE; Levine LS; Carey RM; Greig F; Ulick S; New MI
    J Clin Endocrinol Metab; 1983 Feb; 56(2):332-9. PubMed ID: 6296185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for cortisol as the mineralocorticoid in the syndrome of apparent mineralocorticoid excess.
    Tedde R; Pala A; Melis A; Ulick S
    J Endocrinol Invest; 1992 Jun; 15(6):471-4. PubMed ID: 1401749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistant hypertension in an aged woman presenting with clinical features simulating ectopic ACTH syndrome--response to spironolactone--.
    Harada E; Yasue H; Mizuno Y; Morikawa Y; Nakagawa H; Semba F; Yoshimura M; Saito Y
    Intern Med; 2010; 49(20):2235-9. PubMed ID: 20962442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent mineralocorticoid excess: type I and type II.
    Mantero F; Palermo M; Petrelli MD; Tedde R; Stewart PM; Shackleton CH
    Steroids; 1996 Apr; 61(4):193-6. PubMed ID: 8732999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spironolactone-reversible rickets associated with 11 beta-hydroxysteroid dehydrogenase deficiency syndrome.
    Batista MC; Mendonça BB; Kater CE; Arnhold IJ; Rocha A; Nicolau W; Bloise W
    J Pediatr; 1986 Dec; 109(6):989-93. PubMed ID: 3023598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11 beta-Hydroxysteroid dehydrogenase deficit: a rare cause of arterial Hypertension. Diagnosis and therapeutic approach in two young brothers.
    Gourmelen M; Saint-Jacques I; Morineau G; Soliman H; Julien R; Fiet J
    Eur J Endocrinol; 1996 Aug; 135(2):238-44. PubMed ID: 8810740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinction between Liddle syndrome and apparent mineralocorticoid excess.
    Monnens L; Levtchenko E
    Pediatr Nephrol; 2004 Jan; 19(1):118-9. PubMed ID: 14625721
    [No Abstract]   [Full Text] [Related]  

  • 20. Apparent mineralocorticoid excess syndromes.
    Shimojo M; Stewart PM
    J Endocrinol Invest; 1995; 18(7):518-32. PubMed ID: 9221270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.